Phase II Trial of Arsenic Trioxide in Patients with Metastatic Renal Cell Carcinoma

作者: Jacqueline Vuky , Richard Yu , Lawrence Schwartz , Robert J. Motzer

DOI: 10.1023/A:1016270206374

关键词: AnemiaCarcinomaSurgeryRenal cell carcinomaLiver function testsKidney diseaseGastroenterologyKidneyArsenic trioxideInternal medicineChemotherapyMedicine

摘要: Fourteen patients with metastatic renal cell carcinoma (RCC) were treated on a Phase II trial arsenic trioxide (As2O3). Eligible had bidimensionally measurable disease, Karnofsky performance status of at least 70%, life expectancy greater than three months, and no evidence brain metastases. Arsenic was given intravenously dose 0.3 mg/kg/day for five consecutive days every four weeks. The most common toxicity observed grade elevation in liver function tests (36%), anemia (21%), insufficiency (14%), rash (7%), diarrhea (7%). Best response stable disease 3 one patient remaining study 8+ months At the schedule used this trial, did not achieve complete or partial carcinoma.

参考文章(13)
Gail J. Roboz, Sergio Dias, George Lam, William J. Lane, Steven L. Soignet, Raymond P. Warrell, Shahin Rafii, Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis Blood. ,vol. 96, pp. 1525- 1530 ,(2000) , 10.1182/BLOOD.V96.4.1525
Amato Rj, Chemotherapy for renal cell carcinoma. Seminars in Oncology. ,vol. 27, pp. 177- 186 ,(2000)
Tomoki Naoe, Samuel Waxman, Jian-Hua Ni, Wilson Miller, Shu-Min Xiong, Xun Cai, Zhu Chen, Meng-Min Liu, Pei-Ming Jia, Kunio Kitamura, Jun Zhu, Chao Niu, Guo-Qiang Chen, Sai-Juan Chen, Pascale Paul, Xue-Geng Shi, Kai-Li He, Peng Zhang, Wei Tang, Gui-Ying Shi, Zhen-Yi Wang, Ting-Dong Zhang, Jun Ma, Ze-Guang Han, Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL) : I. As2O3 exerts dose-dependent dual effects on APL cells Blood. ,vol. 89, pp. 3345- 3353 ,(1997) , 10.1182/BLOOD.V89.9.3345
Zhu-Gang Wang, Roberta Rivi, Laurent Delva, Andrea König, David A. Scheinberg, Carlo Gambacorti-Passerini, Janice L. Gabrilove, Raymond P. Warrell, Pier Paolo Pandolfi, Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner. Blood. ,vol. 92, pp. 1497- 1504 ,(1998) , 10.1182/BLOOD.V92.5.1497
S. H. Landis, T. Murray, S. Bolden, P. A. Wingo, Cancer statistics, 1998 CA: A Cancer Journal for Clinicians. ,vol. 48, pp. 6- 29 ,(1998) , 10.3322/CANJCLIN.48.1.6
X.-H. Zhu, Y.-L. Shen, Y.-k. Jing, X. Cai, P.-M. Jia, Y. Huang, W. Tang, G.-Y. Shi, Y.-P. Sun, J. Dai, Z.-Y. Wang, S.-J. Chen, T.-D. Zhang, S. Waxman, Z. Chen, G.-Q. Chen, Apoptosis and Growth Inhibition in Malignant Lymphocytes After Treatment With Arsenic Trioxide at Clinically Achievable Concentrations Journal of the National Cancer Institute. ,vol. 91, pp. 772- 778 ,(1999) , 10.1093/JNCI/91.9.772
T.-C Zhang, E.-H Cao, J.-F Li, W Ma, J.-F Qin, Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide. European Journal of Cancer. ,vol. 35, pp. 1258- 1263 ,(1999) , 10.1016/S0959-8049(99)00106-9
Chao Niu, Hua Yan, Ting Yu, Hui-Ping Sun, Jian-Xiang Liu, Xiu-Song Li, Wen Wu, Fen-Qin Zhang, Yu Chen, Li Zhou, Jun-Min Li, Xiao-Ying Zeng, Ren-Rong Ou Yang, Mi-Man Yuan, Mei-Yu Ren, Feng-Ying Gu, Qi Cao, Bo-Wei Gu, Xin-Ying Su, Guo-Qiang Chen, Shu-Min Xiong, Ting-dong Zhang, Samuel Waxman, Zhen-Yi Wang, Zhu Chen, Jiong Hu, Zhi-Xiang Shen, Sai-Juan Chen, Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood. ,vol. 94, pp. 3315- 3324 ,(1999) , 10.1182/BLOOD.V94.10.3315.422K16_3315_3324
Wenlin Shao, Mirco Fanelli, Fabiana F. Ferrara, Roberta Riccioni, Angelika Rosenauer, Kelly Davison, William W. Lamph, Samuel Waxman, Pier Giuseppe Pelicci, Francesco Lo Coco, Giuseppe Avvisati, Ugo Testy, Cesare Peschle, Carlo Gambacorti-Passerini, Clara Nervi, Wilson H. Miller, Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RARα Protein in Acute Promyelocytic Leukemia Cells Journal of the National Cancer Institute. ,vol. 90, pp. 124- 133 ,(1998) , 10.1093/JNCI/90.2.124
A. B. Miller, B. Hoogstraten, M. Staquet, A. Winkler, Reporting results of cancer treatment Cancer. ,vol. 47, pp. 207- 214 ,(1981) , 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6